| Appearance | White Powder |
| Purity / Analysis Method | Â 99.76% (HPLC) |
| Water | ≤ 2.0% |
| Residue On Ignition (Ash) | ≤ 0.1% |
| Heavy Metals | ≤ 20 ppm |
| Solubility | Slightly soluble in Water and Methanol; Practically insoluble in Hexane |
Active Pharmaceutical Ingredients
Sildenafil Citrate
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine Citrate, 5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one Citrate
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C22H30N6O4S·C6H8O7 = 666.70 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 171599-83-0 |
| Unit | Price |
| 25 g | 2500 |
| 50 g | 3500 |
| 100 g | 4975 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|




